{
    "2021-07-21": [
        [
            {
                "time": "",
                "original_text": "泰格医药：建议进一步修订公司章程",
                "features": {
                    "keywords": [
                        "泰格医药",
                        "公司章程",
                        "修订"
                    ],
                    "sentiment_score": 0.2,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "泰格医药(03347)委任刘准羽为联席公司秘书",
                "features": {
                    "keywords": [
                        "泰格医药",
                        "刘准羽",
                        "联席公司秘书",
                        "委任"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "“药基”明星葛兰、赵蓓等二季度大举增仓这些一线医药公司！（附重仓股）",
                "features": {
                    "keywords": [
                        "葛兰",
                        "赵蓓",
                        "增仓",
                        "医药公司"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "重仓股大“换血”！顶流基金经理最新布局思路曝光",
                "features": {
                    "keywords": [
                        "重仓股",
                        "换血",
                        "基金经理",
                        "布局思路"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药行业2021年中报业绩前瞻：继续保持恢复性增长",
                "features": {
                    "keywords": [
                        "医药行业",
                        "2021年中报",
                        "业绩",
                        "恢复性增长"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}